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Regulation of NF-B, Th Activation,
and Autoinflammation by the
Forkhead Transcription Factor Foxo3a
signaling and metabolism as well as the control of organ-
ismal life span and fertility. Gene targeting in mice has
demonstrated that Foxo1 regulates both insulin sensitiv-
ity (Kitamura et al., 2002; Nakae et al., 2002) and adipo-
cyte differentiation (Nakae et al., 2003), while Foxo3a
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regulates ovarian development and fertility (CastrillonWashington University School of Medicine
et al., 2003; Hosaka et al., 2004).660 South Euclid Avenue
In the immune system, the Foxo members have beenSaint Louis, Missouri 63110
strongly suggested to regulate lymphoid homeostasis
(Birkenkamp and Coffer, 2003). In the human leukemia
T cell line Jurkat, Foxo1 overexpression suppressesSummary
proliferation (Medema et al., 2000), while Foxo3a over-
expression induces apoptosis (Brunet et al., 1999). Simi-Forkhead (Fox) transcription factors play key roles in
larly, Foxo3a overexpression in the murine pre-B cellimmunoregulation. Members of the Foxo subfamily
line Ba/F3 can also induce apoptosis (Dijkers et al.,have been implicated in the regulation of the cell cycle
2002), and in the murine CTLL-2 T cell line, IL-2, viaand/or apoptosis, but their specific immunological
PI3K, leads to the inhibition of Foxo family members,contexts remain largely undefined. We demonstrate
which regulate the cell cycle inhibitor Cdkn1b (p27), thehere that Foxo3a, the predominant Foxo member ex-
proapoptotic Bcl family member Bim (Stahl et al., 2002),pressed in peripheral lymphoid organs, plays a critical
and the antiapoptotic gene glucocorticoid-induced leu-role in lymphoid homeostasis. Foxo3a deficiency leads
cine zipper (GILZ; Asselin et al., 2004). Thus, the Foxo’sto spontaneous lymphoproliferation, associated with
may regulate lymphocyte quiescence (Coffer, 2003; Yu-inflammation of several organs, in the absence of overt
suf and Fruman, 2003); however, these studies haveapoptotic defects. These findings correlated with the
primarily been confined to transformed or cultured lym-presence of hyperactivated helper T cells, which prolif-
phocyte cell lines, rather than primary cells.erated more vigorously and produced more Th1 and
Nonetheless, a clinically relevant immunoregulatoryTh2 cytokines than their wild-type counterparts.
role for the Foxo family members remains likely, sinceFoxo3a inhibits NF-B activation, whose overactivity
a growing number of forkhead genes are being demon-was responsible for T cell hyperactivity in Foxo3a-
strated to regulate T cell activation, homeostasis, anddeficient mice. Thus, Foxo3a regulates helper T cell
tolerance: Foxp3, for example, has received attentionactivation and tolerance by inhibiting NF-B activity,
for its role in regulatory CD4CD25 T cells (Fontenotreinforcing a generalized role for the forkhead proteins
et al., 2003; Hori et al., 2003; Khattri et al., 2003), andin the maintenance of T cell tolerance through the
Foxn1 is required for T cell development due to its roleinhibition of inflammatory transcriptional activities.
in thymic epithelium (Frank et al., 1999). In addition,
attention to Foxj1 has developed in our laboratory duringIntroduction
studies in systemic lupus erythematosus (SLE), a sys-
temic autoimmune syndrome characterized by the de-The Foxo subfamily of forkhead transcription factors
velopment of pathogenic autoantibodies, such as anti-includes at least four members, Foxo1 (Fkhr), Foxo3a
DNA, which mediate lethal end-organ disease, such as(Foxo3, Fkhrl1), Foxo4 (Afx), and Foxo6 (Jacobs et al.,
glomerulonephritis (Mills, 1994). Foxj1 expression is sig-
2003), which have been implicated in the regulation of
nificantly diminished in lymphocytes from lupus-prone
the cell cycle and apoptosis (Birkenkamp and Coffer,
mouse strains, which recapitulate the immune-complex
2003; Tran et al., 2003). In the absence of environmental pathogenesis of the human disease, but not nonauto-
signals or growth factors, the Foxo family members re- immune strains (Andrews et al., 1978; Lin et al., 2004).
main transcriptionally active in the nucleus. Relevant Foxj1-deficient T cells demonstrate accentuated prolif-
growth factors activate the phosphatidylinositol 3-kinase eration and cytokine responses to antigen receptor and
(PI3K)-Akt (protein kinase B, PKB) signaling pathway, mitogenic signaling, leading to autoreactivity and multi-
phosphorylating the Foxo proteins and rendering them system organ inflammation resembling the cellular auto-
susceptible to 14-3-3-assisted nuclear export, abrogat- immunity of lupus. These effects reflect a requirement
ing transcriptional activity (Tran et al., 2003). In this way, for Foxj1 to suppress spontaneous NF-B activity in
the PI3K-Akt-Foxo pathway has been proposed to mod- naive T cells, likely via the activation of IB proteins
ulate diverse biological processes, including cell sur- (Lin et al., 2004). Since hyperactivity of NF-B has been
vival, proliferation, apoptosis, and stress responses via implicated in the pathogenesis of multiple autoimmune
target genes including GADD45, Cdkn1a/p21, Cdkn1b/ syndromes, including SLE (Peng, 2004), an elucidation
p27, cyclin B, and Bim (Birkenkamp and Coffer, 2003; of the mechanisms by which the forkhead transcription
Brunet et al., 2004; Motta et al., 2004; Tran et al., 2003). factors and/or other immunoregulatory genes regulate
The Foxo genes are the mammalian homologs of NF-B activity will likely provide insight into the patho-
Caenorhabditis elegans DAF-16, which regulates insulin genesis of autoimmunity in general.
During ongoing studies, we have found that Foxo3a,
like Foxj1, can also inhibit NF-B activation, suggesting*Correspondence: speng@wustl.edu
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Figure 1. Foxo3a Is an NF-B Antagonist
(A) Spontaneous activity of an NF-B-lucifer-
ase reporter in M12 cells was assessed in the
presence of control (pcDNA), Foxj1-express-
ing (pcDNA-Foxj1), or Foxo3a-expressing
(pcDNA-Foxo3a) expression vectors. Induc-
ibility of an NF-B-luciferase reporter construct
was assessed in 293T cells in the presence
(black bars) or absence (open bars) of TNF-,
in the presence of control (pcDNA), Foxj1-
expressing (pcDNA-Foxj1), or Foxo3a-express-
ing (pcDNA-Foxo3a) expression vectors.
(B) Similar studies were performed in M12
and 293T cells in the presence of control,
Foxm1-, or Foxq1-expressing vectors.
(C) Nuclear translocation capabilities of RELA
in 293T cells was assessed in the presence
or absence of Foxo3a. After retroviral tran-
duction with a control (pMX-IRES-GFP) or
Foxo3a-expressing (pMX-Foxo3a-IRES-GFP)
retrovirus, cells were stimulated with TNF-
for 45 min and stained for RELA by immuno-
histochemistry (red). All cells shown were
GFP positive (green fluorescence not shown).
Percentages indicate the number of cells, per
100 GFP-positive cells, that demonstrated
nuclear RELA staining.
(D) Spontaneous Foxo activity was assessed
in naive Th cells from nonautoimmune
(BALB/c, C57BL/6) versus lupus-prone
(BXSB, MRL/lpr) mice using a 6XDBE-lucifer-
ase reporter.
(E) Naive CD4 T cells were isolated from
wild-type C57BL/6 mice and incubated in the
presence (black bars) or absence (open bars)
of 1 g/ml plate bound anti-CD3, as well as,
where indicated, soluble anti-CD28 and/or re-
combinant IL-2. After 24 hr, expression of
Foxo3a was determined by real-time PCR.
Error bars indicate the standard deviations
of three simultaneously performed samples,
representative of three experiments.
that Foxo3a may have similar immunoregulatory func- Foxo3a) but was consistently comparable to, if not more
effective than, Foxj1 in 293T cells (note the lower lucifer-tions in vivo. Indeed, in the absence of functional
Foxo3a, mice develop a spontaneous, multisystemic in- ase activity in the presence of Foxo3a versus Foxj1,
whether or not treated with TNF). Foxo3a overexpres-flammatory syndrome associated with lymphadenopa-
thy, increased NF-B activation, and hyperactivation of sion could also inhibit TNF-induced nuclear transloca-
tion of the RELA NF-B subunit in 293T cells (Figure 1C;CD4 T cells, similar to Foxj1 deficiency. Thus, Foxo3a
also regulates autoimmunity and helper T cell activation, p  0.001, comparing Foxo3a to control). Thus, like
suggesting a general role for the forkhead genes in the Foxj1, Foxo3a is an NF-B antagonist.
control of lymphocyte tolerance. Since the in vivo NF-B hyperactivity that results from
Foxj1 deficiency may contribute to the T cell hyperactiv-
ity and tolerance loss in autoimmune diseases like SLEResults and Discussion
(Lin et al., 2004), Foxo3a deficiency might likewise con-
tribute to autoimmunity by allowing NF-B hyperactivityIdentification of Foxo3a as an NF-B Antagonist
and T cell autoactivation. To explore this possibility, wewith Depressed Activity in Autoimmunity
first assessed endogenous Foxo activity in naive T cellsDuring ongoing studies with Foxj1, we wondered if
purified from nonautoimmune and lupus-prone animalsNF-B repression was a unique characteristic of Foxj1,
at 5–6 weeks of age, several weeks before the onset ofand we tested the ability of several forkhead members
clinically apparent disease (Andrews et al., 1978). Asto inhibit NF-B activity in vitro. Intriguingly, Foxo3a,
judged by a Foxo-luciferase reporter, Foxo activity wasbut not Foxm1 or Foxq1, could suppress NF-B activity
significantly lower in Th cells from lupus-prone, com-in both M12 and 293T cells (Figures 1A and 1B). It consis-
pared to nonautoimmune, mice (Figure 1D; p  0.0001,tently was not as effective as Foxj1 in M12 cells in sup-
comparing either BXSB or MRL/lpr to BALB/c or C57BL/6).pressing spontaneous NF-B activity (p 0.10, compar-
ing luciferase activity in the presence of Foxj1 versus Since Foxo3a is the dominant Foxo member expressed
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wild-type Foxo3a may form as a result of alternative
splicing around the targeting vector. In addition, al-
though we have failed to detect truncated forms of
Foxo3a that might correspond to exon 2 using antibod-
ies that recognize the form of Foxo3a phosphorylated
at Thr-32 (data not shown), we cannot rule out the possi-
bility that finite levels of such a truncated Foxo3a, unde-
tectable by our assays, are also produced. Therefore,
we refer to the genotype of these animals as trap/trap.
Trap/trap animals appeared outwardly healthy until
at least 8 months of age, although females were infer-
tile after 12 weeks of age due to abnormal ovarian follicu-
lar development, consistent with previously described
Foxo3a-targeted alleles (Castrillon et al., 2003; Hosaka
et al., 2004). Histopathological examination of older (16
Figure 2. Targeting of the Murine Foxo3a Locus
week) animals revealed that they suffered from multisys-
(A) Genomic organization of murine Foxo3a, with the insertion site tem inflammation, particularly of the salivary gland, lung,
of the gene-trap vector in BayGenomics ES cell line XA026, as
and kidney (Figure 3; p  0.0001, comparing / todetermined by our laboratory, indicated by an arrow. Roman numer-
trap/trap for involvement of any organ shown). Immuno-als indicate exon numbers. The start (ATG) and stop (TGA) sites of
the coding exons are indicated. histochemical examination revealed a mixed infiltrate of
(B) PCR-based genotyping of the Foxo3a trapped allele. Tail DNA from CD4 and B220 cells, suggesting a lymphoid, presum-
mice of the indicated genotypes was amplified by standard PCR. ably T-dependent, infiltrate. In addition, lymphoprolifer-
(C) Western blotting of thymi from 4-week-old/ or trap/trap mice ation was evident, with splenic and lymph node sizes
was performed using a polyclonal antibody raised against the whole
and cellularities typically 1.75–2 times their / lit-Foxo3a molecule. Foxo1-specific antibodies were used as a loading
termates (Figures 4A and 4B; p 0.01, comparing cellu-control. En2, engrailed 2; SA, splice acceptor site.
larity of trap/trap to/ for either spleen or lymph node).
This lymphadenopathy did not reflect a generalized or-
ganomegaly, since trap/trap animals developed hearts,in peripheral lymphoid organs (Biggs et al., 2001; Furu-
kidneys, thymi, and livers of weights comparable toyama et al., 2000), these findings suggest that loss of
their / counterparts (22.3  1.6 versus 22.4  1.5function of Foxo3a might indeed be responsible at least
mg, 23.0  1.0 versus 23.9  0.9 mg, 39.3  1.4 mgin part for NF-B hyperactivation in these lupus-prone
versus 39.0  1.0 mg, and 1.54  0.16 versus 1.53 mice. Interestingly, the RNA expression and activity pat-
0.13 g, respectively; n 5 of each genotype). The lymph-tern of Foxo3a in conventional, nonautoimmune Th cells
adenopathy was composed almost entirely of T cells, asis highly reminiscent of Foxj1, being highly expressed
evidenced by flow cytometric analyses of these organs,and active in naive Th cells and diminishing rapidly upon
with B cell numbers remaining largely constant be-anti-CD3 and/or IL-2 stimulation, also supporting this
tween / and trap counterparts (Table 1; Supplemen-notion (Figure 1E; Lin et al., 2004; Stahl et al., 2002).
tal Figure S1 at http://www.immunity.com/cgi/content/Thus, as an NF-B antagonist with depressed activity
full/21/2/203/DC1). Interestingly, the CD4/CD8 ratio ofin Th cells from lupus-prone mice and a predominant
T cells remained largely normal, with approximately 2–3expression in naive Th cells, Foxo3a might exert an anti-
times as many CD4 as CD8 cells in all organs tested ofinflammatory function in T cells in vivo.
both / and trap/trap animals. Nonetheless, trap/trap
CD4 T cells appeared somewhat activated, with mod-Autoinflammation and Lymphoproliferation
est upregulation of CD44 and CD25, as well as downreg-in the Absence of Foxo3a
ulation of CD45RB, compared to their / littermates.To test this, we derived animals deficient in Foxo3a
These findings were unlikely to reflect a role for Foxo3aby generating animals bearing a disabled Foxo3a allele
in the development of regulatory T cells, since theusing the BayGenomics XA026 embryonic stem cell line,
CD25CD62LCD4 population was, if anything, pro-which was derived during a gene-trap targeting strategy
portionally increased in trap/trap animals. In addition,(Figure 2). Our genetic analysis of the cell line deter-
trap/trap animals did not demonstrate significant hyper-mined the gene-trap insertion site to be located 5 kb
gammaglobulinemia or autoantibody production, asdownstream of the first coding exon, such that the
judged by tests for serum Ig, antinuclear antibodies,strong splice acceptor (SA) site of the insert would result
rheumatoid factor or anti-dsDNA, or gross abnormalitiesin aberrant splicing of the transcript (Figure 2A). Germ-
in B cell subsets (Table 1; Supplemental Figure S1, andline transmission of this allele was achieved (Figure 2B),
data not shown), suggesting that the inflammatory phe-and intercross of heterozygotic animals yielded /,
notype predominantly reflected T, not B, cell hyperac-/trap, and trap/trap animals of approximately Mende-
tivity.lian ratios. When examined by Western blot, Foxo3a
was undetectable in thymi of trap/trap animals (Figure
2C). Thus, the targeted mutation of XA026 appears to Th Hyperactivation and Normal Apoptosis
in the Absence of Foxo3abe a null allele. However, although we have been unable
to detect mature mRNA corresponding to exons 2–3 of Given the prior implications for Foxo3a in the regulation
of apoptosis (Birkenkamp and Coffer, 2003; Coffer,the Foxo3a gene in trap/trap thymi (not shown), we can-
not rule out the possibility that finite levels of mature, 2003), an immediately obvious explanation for the in-
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Figure 3. Autoimmune Inflammation in the
Absence of Foxo3a
Note the heterogeneous inflammation of the
organs in Foxo3a trap/trap animals, in con-
trast to normal-appearing tissues in /
counterparts. Each panel is from a different
animal, representative of 10 animals exam-
ined for each genotype at 20 weeks of age.
Original magnification, 20	 for all panels.
flammatory and lymphoproliferative phenotype in trap/ IL-2, respectively; p  0.001 for all conditions except
no stimulus; n  3 for each genotype).trap mice involves defects in activation-induced cell
death or other apoptotic phenomena in T cells, reminis- Naive CD4 trap/trap T cells generally also prolifer-
ated better than their / counterparts (Figure 5A; p cent of the autoimmune and lymphoproliferative pheno-
type of animals with defects in CD95 or CD178 (Cohen 0.001, comparing trap/trap to /, for 10 g/ml anti-
CD3 alone and 1 and 3 g/ml anti-CD3 supplementedand Eisenberg, 1991). However, trap/trap T cells were
not impaired in their ability to undergo apoptosis, as with IL-2), but these differences were modest compared
to the differences seen with bulk CD4 T cells, sug-judged by assays for activation-induced cell death; IL-2
withdrawal; anti-CD3-mediated deletion of CD4CD8 gesting that a significant proportion of trap/trap T cells
undergo primary stimulation in vivo, presumably to au-thymocytes in vivo; anti-CD95-induced lethal multisys-
tem apoptosis in vivo; and anti-CD95, PMA, or iono- tologous antigens (Lin et al., 2004). Indeed, trap/trap,
but not /, T cells proliferate vigorously in autologousmycin-mediated apoptosis in vitro (data not shown). As
such, we conclude that Foxo3a is largely dispensable mixed lymphocyte reactions (Figure 4D), suggesting
strongly that autoreactive trap/trap T cells are acti-for immunoregulation by apoptosis.
As a result, lymphoproliferation in the absence of vated in vivo.
All the same, naive trap/trap CD4 T cells were clearlyFoxo3a must instead have reflected defects in the regu-
lation of T cell proliferation and/or activation. Indeed, more hyperactivatable than their / counterparts, as
evidenced by significantly increased IL-2 productionbulk CD4 T cells from trap/trap mice proliferated much
more vigorously than their / counterparts, requiring (p  0.001 at all conditions tested with anti-CD3  1
g/ml) and IFN-
 production (p 0.001 at all conditionsonly IL-2 in the absence of anti-CD3 or anti-CD28 for
significant proliferation (Figure 4C; p0.001, comparing tested with anti-CD3 3 g/ml supplemented with anti-
CD28  IL-2; Figure 5B). Similarly, under Th2-polarizingtrap/trap to /, for all conditions tested without anti-
CD28, for all anti-CD3 concentrations also stimulated conditions, trap/trap Th cells consistently produced in-
creased amounts of the Th2 cytokines IL-4, IL-5, IL-6,with anti-CD28 and IL-2, and for all anti-CD3 concentra-
tions 1 g/ml also stimulated with anti-CD28). Similar and IL-10 (Figure 5C; p  0.001 at all conditions tested
with anti-CD3  1 g/ml). Interestingly, trap/trap CD4results were observed when percentages of BrdU-posi-
tive cells were assessed by flow cytometry (e.g., 0.23  cells exhibited less dramatic differences from their /
counterparts for both IL-2 and IFN-
 production when0.08 versus 0.21  0.08, 0.2  0.03 versus 14.0  1.0,
7.7 1.0 versus 17.6 1.9, and 20.7 3.8 versus 44.0 stimulated in the presence of IL-2 (Figure 5B; e.g., com-
pare cells stimulated with anti-CD3 and IL-2 without4.2, comparing/ to trap/trap Th cells stimulated with
no stimulus, IL-2 alone, anti-CD3 alone, or anti-CD3 and anti-CD28), consistent with the ability of IL-2 to induce
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Figure 4. Lymphadenopathy, T Cell Hyper-
proliferation, and Autoreactivity in the Ab-
sence of Foxo3a
(A) Gross photomicrographs of spleens from
8-week-old / or trap/trap mice.
(B) Cellularity of spleens and lymph nodes
from 8-week-old / or trap/trap mice (n 
5 in each group).
(C) Proliferative capacity of bulk CD4 T cells
from Foxo3a/ (squares) and trap/trap (cir-
cles) animals, stimulated with the indicated
amounts of plate bound anti-CD3 in the pres-
ence (black) or absence (open) of IL-2, with
(lower panel) or without (upper panel) anti-
CD28.
(D) Autologous mixed lymphocyte reactivity
of CD4 T cells from Foxo3a/ (open bars)
or trap/trap (black bars) mice. Th cells were
incubated in the presence or absence of au-
tologous splenic antigen presenting cells
(APC) and assessed for proliferation by BrdU
incorporation on day 3. Both / and trap/
trap cells proliferated vigorously (OD 2.0) to
concanavalin A (not shown). Error bars repre-
sent standard deviations of cells from three
individual mice, representative of three inde-
pendent experiments.
a Foxo3a deficiency by both suppressing RNA synthesis animals would reflect its role in the regulation of inhibi-
tory NF-B proteins, such as the IB family membersand inactivating the mature protein (Figure 1E; Stahl et
al., 2002). Foxo3a deficiency thus leads to dysregulated (Li and Verma, 2002). Naive trap/trap Th cells contained
significantly less IB and IB, but not IB, RELA, orTh cytokine production, hyperactivation, hyperprolifera-
tion, and inflammation, in part by mimicking IL-2 stimu- p50, mRNA than their/ counterparts (p 0.01, Figure
6C), and demonstrated significantly less IB and IBlation.
protein by Western analysis (Figure 6D), consistent with
this possibility. However, the importance of Foxo3a inRole of NF-B Activation in the Absence of Foxo3a
the regulation of IB and IB transcription may beBased upon the parallel findings between Foxj1, Foxo3a,
indirect: an examination of the putative promoter re-and NF-B (Figure 1; Lin et al., 2004), NF-B hyperactiva-
gions of these genes reveals no Foxo binding sitestion should be present and account for the hyperactive
(TTGTTTAC), and Foxo3a fails to transactivate eitherphenotype of trap/trap animals. Indeed, as judged by an
an IB- or IB-promoter-luciferase construct in vitroNF-B-luciferase reporter, naive trap/trap CD4 T cells
(Budde et al., 2002; Lin et al., 2004; and our unpublisheddemonstrated higher spontaneous NF-B, but not NF-AT,
data). Interestingly, trap/trap T cells also contained sig-activity compared to their / counterparts (Figure 6A;
nificantly less Foxj1 RNA than their / counterpartsp  0.001) and blockade of NF-B activity via double-
(Figure 6C), suggesting that Foxo3a may actually regu-stranded decoy NF-B oligonucleotides, encoding the
late IB transcription via Foxj1 (Lin et al., 2004); however,consensus binding site for all NF-B subunits, effec-
Foxj1 primary regulates IB, not IB (Lin et al., 2004),tively abrogated the hyperactivity, which was best evi-
so Foxo3a likely regulates the IB’s by additional mech-denced by IL-2 overproduction (Figures 5B and 6B; p 
anisms. Regardless, these findings together demonstrate0.0001, comparing T cells treated with decoy or control
that Foxo3a prevents autoimmunity and lymphoprolifera-decoy oligonucleotides). Thus, trap/trap T cells demon-
tion by suppressing inflammatory transcriptional activitiesstrate NF-B hyperactivation, which accounts for the
like NF-B, perhaps via other anti-inflammatory tran-T cell hyperfunction.
scriptional regulators like Foxj1, but nevertheless ulti-Given the role of Foxo3a as a transcription factor, a
likely explanation for NF-B hyperactivation in trap/trap mately via the IB proteins.
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Table 1. Cellularity of Lymphoid Organs in the Absence of Foxo3a
Calculated Number (	 106)
Total CD3 B220 CD4 CD8
Genotype Organ (	 106) (%) (%) (% of CD3) (% of CD3) CD3 B220 CD4 CD8
/ Spleen 50 41 58 71 27 21 29 15 5.5
/ Spleen 70 45 55 69 30 32 39 22 9.5
/ Spleen 61 39 60 73 26 24 37 17 6.2
/ Spleen 65 42 58 72 26 27 38 20 7.1
/ Spleen 57 41 59 74 25 23 34 17 5.8
Avg 61 42 58 72 27 25 35 18 6.8
Stdev 7.6 2.2 1.9 1.9 1.9 4.2 3.9 2.7 1.6
/ L. Node 20 74 25 69 30 15 5.0 10 4.4
/ L. Node 24 78 22 73 27 19 5.3 14 5.1
/ L. Node 21 79 20 73 26 17 4.2 12 4.3
/ L. Node 26 72 28 72 28 19 7.3 13 5.2
/ L. Node 29 71 27 70 29 21 7.8 14 6.0
Avg 24 75 24 71 28 18 5.9 13 5.0
Stdev 3.7 3.6 3.4 1.8 1.6 2.2 1.6 1.7 0.7
trap/trap Spleen 96 63 36 70 29 60 35 42 18
trap/trap Spleen 90 68 32 68 30 61 29 42 18
trap/trap Spleen 105 60 39 69 30 63 41 43 19
trap/trap Spleen 107 62 37 73 26 66 40 48 17
trap/trap Spleen 120 61 39 72 27 73 47 53 20
Avg 104 63 37 70 28 65 38 46 18
Stdev 11.5 3.1 2.9 2.1 1.8 5.2 6.8 4.7 1.0
trap/trap L. Node 45 87 10 72 27 39 4.5 28 11
trap/trap L. Node 58 86 13 73 27 50 7.5 36 13
trap/trap L. Node 40 89 11 69 31 36 4.4 25 11
trap/trap L. Node 43 84 15 70 30 36 6.5 25 11
trap/trap L. Node 62 90 9.8 76 25 56 6.1 42 14
Avg 50 87 12 72 28 43 5.8 31 12
Stdev 9.8 2.4 2.2 2.7 2.4 9.1 1.3 7.8 1.6
Spleens and lymph nodes (L. Node) of animals were assessed at 10–12 weeks of age using flow cytometry. Averages (Avg) and standard
deviations (Stdev) are shown.
The Role of Foxo3a in the Regulation of Foxj1 to Foxo3a in nonirradiated animals, such as
through the use of a Foxj1 conditional allele, and/or toof T Cell Activation
Along with findings regarding Foxj1 (Lin et al., 2004), the determine the relative importance of the various IB
family members to specific autoimmune syndromes, be-present findings suggest a general role for forkhead
transcription factors in the intrinsic enforcement of T cell yond their generally accepted roles as generic anti-
inflammatory agents (Li and Verma, 2002).quiescence and/or tolerance. The phenotype of Foxo3a
deficiency is highly reminiscent of Foxj1 deficiency, in- Despite substantial suggestions in the literature (Tran
et al., 2003), Foxo3a appears to be largely dispensablecluding multisystem end-organ inflammation as well as
T cell and NF-B hyperactivation. Nonetheless, there are for the induction of apoptosis or activation-induced cell
death in T cells. These results do not entirely rule outclear differences between Foxj1 and Foxo3a: whereas
Foxj1 deficiency led to a severe, essentially lethal inflam- the possibility that Foxo3a regulates T cell apoptosis in
certain contexts but suggest that its major functionmatory syndrome affecting multiple vital organs, at least
in chimeric animals using irradiated recipients (Lin et in vivo is antiproliferative or antiactivation by regulating
anti-inflammatory or antiactivation targets like the IBal., 2004), Foxo3a deficiency here in spontaneous, native
animals leads to a mild, apparently nonlethal inflamma- proteins. Alternatively, Foxo3a may regulate cell cycle
proteins, like p27kip1 (Chandramohan et al., 2004; Med-tion, predominantly affecting the salivary gland. In addi-
tion, Foxj1 deficiency led to Th1 hyperactivation in vivo, ema et al., 2000), but the absence of spontaneous prolif-
eration by naive trap/trap T cells argues against thiswhereas Foxo3a deficiency here resulted in global hy-
peractivation of both Th1 and Th2 cells, and while possibility (Figure 5). At the same time, Foxo3a itself
can be regulated by IB kinases (Hu et al., 2004), sug-Foxj1’s NF-B antagonist activity could be attributed
solely to its regulation of IB, Foxo3a regulates at least gesting a regulatory network comprised of the NF-B
and Foxo systems: on one hand, the IB kinases canboth IB and IB. These differences likely account for
the partly overlapping but still independent anti-inflam- amplify NF-B activity by initiating the degradation of
both IB proteins and Foxo3a. On the other hand, cessa-matory pathways regulated by both Foxo3a and Foxj1
in vivo, resulting in the differences in target organ tion of IB kinase activity can result in Foxo3a reactiva-
tion and subsequent induction of IB gene transcription,involvement, Th1 versus Th2 cytokine production, etc.
As such, it will be of interest to compare the activity inhibiting NF-B activity. Thus, Foxo3 likely modulates
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Figure 5. Hyperactivation of T Cells in the
Absence of Foxo3a
(A) Proliferative capacity of naive CD4T cells
from Foxo3a/ (squares) and trap/trap (cir-
cles) animals, stimulated with the indicated
amounts of plate bound anti-CD3 in the pres-
ence (black) or absence (open) of IL-2, with
(right panel) or without (left panel) anti-CD28.
(B) Secreted cytokines produced by naive
CD4 T cells from Foxo3a / (squares) ver-
sus trap/trap (circles) animals, stimulated
with the indicated amounts of plate bound
anti-CD3 in the presence (black) or absence
(open) of IL-2, with (right panel) or without
(left panel) anti-CD28.
(C) Naive T cells from Foxo3a / (squares)
versus trap/trap (circles) animals were differ-
entiated under Th2 polarizing conditions
in vitro for 1 week, followed by stimulation
with the indicated doses of anti-CD3. After
20 hr, cytokine secretion was assessed by
ELISA. Standard deviations reflect triplicate
samples, representative of four separately
performed experiments.
activation thresholds as part of a closely coordinated Still, it will be of interest to compare the immunological
phenotypes of these various Foxo3a alleles, particularlysignaling network in the Th cell, effectively reducing cell
metabolism while maintaining the resting, naive cell in older animals, to determine if the autoinflammatory
syndrome reflects differences in environment and/or ge-state.
Recent studies on different Foxo3a deficiencies did netics.
Finally, the present findings suggest that loss of func-not report the immunological abnormalities, including
autoinflammation, described here (Castrillon et al., 2003; tion in Foxo3a, other Foxo family members, and/or their
respective metabolic pathways may contribute to theHosaka et al., 2004). However, those analyses did not
specifically address the immune system, and histologi- pathogenesis of autoimmune diseases by lowering the
threshold for activation and tolerance loss. However,cal analyses of organs were performed at 9 weeks of
age, well before the 16–20 weeks of age at which the since isolated loss of function of Foxo3a fails to cause
as severe an inflammatory phenotype as inbred lupus-trap/trap mice of the present study exhibited disease.
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Figure 6. NF-B Overactivation in the Ab-
sence of Foxo3a
(A) NF-B- and NF-AT-luciferase activity was
assessed in primary CD4 T cells derived
from Foxo3a / versus trap/trap animals.
(B) Naive T cells from Foxo3a trap/trap ani-
mals were stimulated in vitro with plate bound
anti-CD3 (3g/ml) in the presence or absence
of decoy NF-B or control mismatch (MM)
oligonucleotides. On day 3, IL-2 secretion
was evaluated by ELISA on culture super-
natants. Under these conditions, wild-type
T cells fail to produce significant levels of IL-2
(Figure 5 and not shown).
(C) Levels of IB, RELA, p50, and Foxj1
mRNAs were assessed by real-time PCR in
naive Th cells from Foxo3a / versus trap/
trap animals.
(D) Levels of IB proteins were assessed by
Western blot in naive Th cells from Foxo3a/
(wt) versus trap/trap animals. Error bars indi-
cate the standard deviations of three simulta-
neously performed samples, representative
of two experiments.
CACCACCACCAACCTACAC and 5-GAAGATCTCCGAGCGGCTTprone mice, multiple polygenetic defects are likely re-
CATTACCTGCC, which produced a515 bp fragment correspond-quired to culminate in an extreme, disease-inducing
ing to the putative IB promoter (497 to 118, respective to theNF-B hyperactivity. Such considerations suggest the
transcriptional start site), flanked by KpnI and BglII restriction sites.
potential importance of an examination of lymphoid sys- The amplicon was cloned into the KpnI-BglII sites of TK-luc (Szabo
tems multiply deficient for Foxo3a, Foxj1, and/or other et al., 2000) and then confirmed by routine sequencing. To generate
a Foxo3a expression plasmid, a BamHI-XhoI fragment containingtranscription factors that also inhibit NF-B yet are di-
the full-length human Foxo3a cDNA (IMAGE clone 4137370, ATCC,minished in activity in autoimmune conditions. Such
Manassas, VA) was directionally cloned into the BamHI-XhoI sites ofcontinued investigation will undoubtedly shed further
pcDNA3 (Invitrogen, Carlsbad, CA). To generate a retroviral Foxo3ainsight into the mechanisms of T cell tolerance, quies-
expression plasmid, the same Foxo3a cDNA fragment was direc-
cence, and activation. tionally cloned into the BamHI-XhoI sites of pMX-IRES-GFP (Lin et
al., 2004; Morita et al., 2000; Onishi et al., 1996). pCMV-SPORT6-
Experimental Procedures derived Foxm1- and Foxq1-expression plasmids were obtained
from the ATCC (IMAGE clones 3881055 and 6489152, respectively).
Mice pCMV-SPORT6c (control pCMV-SPORT6) was generated by excis-
129, BALB/c, BXSB/MpJ, MRL/MpJ-CD95lpr/lpr (MRL/lpr), and ing the SalI-NotI fragment containing the Foxm1 cDNA from pCMV-
C57BL/6 mice were obtained from the Jackson Laboratory (Bar SPORT6-Foxm1. Retroviral supernatants were prepared in PlatE
Harbor, ME). To generate Foxo3a-deficient mice, we utilized chime- cells, and T and 293T cell transductions were performed as de-
ric animals derived from the BayGenomics ES cell line XA026, ob- scribed (Lin et al., 2004; Morita et al., 2000; Onishi et al., 1996).
tained from the Mutant Mouse Regional Resource Center, University
of California at Davis (Davis, CA). The mutant allele was backcrossed
Luciferase Studiesthree times against the 129 background before intercross of hetero-
Reporter assays were performed essentially as described (Lin etzygotic animals to generate / or trap/trap littermates for use in
al., 2004). Briefly, for assays in M12 murine B cell lymphoma cells,this study. Genotype was determined by PCR on tail DNA using
107 cells in 400 l complete RPMI medium were electroporated inprimers 5-AGTAACGGGCTTCCTCTTTCTCCTGTC, 5-CTCTCCAG
a 0.4 cm cuvette at 280 mV, 975 F in the presence of 10 gCCCTAGAAATCCAAACTC, and INV86R, 5-CACTCCAACCTCCG
2	 NF-B-luc, 40 ng pRL-CMV (Renilla luciferase control reporter,CAAACTC (BayGenomics). All mice were maintained under specific
Promega, Madison, WI), and 10 g pCDNA3 (Invitrogen), pcDNA3-pathogen-free conditions, and all experiments were performed in
Foxj1 (Lin et al., 2004), pcDNA3-Foxo3a, pCMV-SPORT6c, pCMV-compliance with the relevant laws and institutional guidelines, as
SPORT6-Foxm1, or pCMV-SPORT6-Foxq1, and then returned tooverseen by the Animal Studies Committee of the Washington Uni-
cell culture medium. After 4 hr, reporter activity was determined byversity School of Medicine.
the Dual-Luciferase Reporter Assay System (Promega) and relative
activity determined after normalization for Renilla luciferase. ForPlasmids and Retroviruses
the 293T transformed human embryonic kidney line, 0.1–0.2 	 106An IB promoter-reporter construct was constructed by PCR from
C57BL/6 genomic DNA, using primers 5-GGGGTACCACCCCAC adherent cells in DMEM medium with 10% fetal calf serum were
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transfected with 2g NF-B-luc, 10 ng pRL-CMV, and 2g pcDNA3, fresh retroviral supernatants of pMX-IRES-GFP versus pMX-
Foxo3a-IRES-GFP viruses. 24 hours later, cells were treated withpcDNA3-Foxj1, pcDNA-Foxo3a, pCMV-SPORT6c, pCMV-SPORT6-
Foxm1, or pCMV-SPORT6-Foxq1, using FuGENE 6 (Roche). 24 hr or without 20 ng/ml TNF- for 45 min prior to fixation in 100%
methanol (Sigma) for 5 min,20C. The coverslips were then washedlater, cells were stimulated with 20 ng/ml recombinant human TNF-
(PeproTech), and 4 hr thereafter cells were analyzed via the Dual- thrice with PBS, blocked with 10% normal goat serum in PBS, incu-
bated with primary antibody (C20, rat anti-RELA, Santa Cruz Bio-Luciferase assay, with relative activity determined after normaliza-
tion for Renilla. For primary T cells, 2	 107 purified naive CD4 cells technology) at 1:100 dilution in PBS for 60 min in a humidified cham-
ber, washed thrice with PBS, incubated with PE goat anti-rabbitwere electroporated with 20g NF-B-luc, NF-AT-luc, or 6XDBE-luc
(a Foxo reporter; Furuyama et al., 2000), as indicated, as well as 0.4 IgG (Southern Biotechnology) at 1:100 dilution in PBS for 45 min,
mounted on glass slides, and visualized by fluorescence micros-g of pRL-CMV, with relative activity determined after normalization
for Renilla. copy. Nuclear versus cytoplasmic staining of NF-B proteins was
determined in GFP-positive cells.
Flow Cytometry
Western BlottingFlow cytometric analyses were performed on a FACSCalibur System
Total cell lysates were resolved by 7.5% SDS-PAGE electrophoresis(BD Biosciences, San Diego, CA) using splenocytes cleared of red
and blotted to nitrocellulose. Membranes were blocked with 5%blood cells by osmotic lysis or lymph node cells. Antibodies used
nonfat dried milk (Sigma), incubated with primary antibody at 1:200included: FITC-16A (anti-CD45RB), APC-53-7.3 (anti-CD5), FITC-
dilution for 1 hr, washed thrice with PBS containing 0.05% Tween-207D4 (anti-CD25), PE-IM7 (anti-CD44), PE-MEL-14 (anti-CD62L),
(Sigma), incubated with HRP-conjugated mouse anti-goat or donkeyCyChrome-RA3-6B2 (anti-CD45R/B220), PE-R6-60.2 (anti-IgM), and
anti-rabbit IgG (Pierce, Rockford, IL) at 1:5000 dilution for 1 hr,CyChrome-RM4-4 (anti-CD4; BD Pharmingen, San Diego, CA).
washed thrice with PBS-Tween, and then developed using ECL
Western Blotting Detection Reagents (Amersham Biosciences, Pis-Lymphocyte Cultures and In Vitro Differentiation
cataway, NJ) and BioMax MR film (Eastman Kodak Co., Chicago,For bulk CD4 Th cell analyses, splenocytes were cleared of erythro-
IL). Primary antibodies included: polyclonal anti-whole Foxo3acytes by osmotic lysis, and CD4 cells purified by positive magnetic
(FKHRL1, Upstate, Lake Placid, NY) and polyclonal anti-Foxo1bead selection (Miltenyi Biotec, Auburn, CA). For naive-enriched
(FKHR, Santa Cruz).CD4 Th cell analyses, lymph node cells from cervical, axillary,
brachial, inguinal, and popliteal nodes were first cleared of CD8,
HistopathologyMHCII, and CD44 cells by negative magnetic bead selection (Mil-
Tissue histology was performed on buffered formalin-fixed, paraffin-tenyi Biotec), followed by positive CD4 magnetic selection. In gen-
imbedded specimens with routine hematoxylin and eosin staining.eral, cells were then incubated in complete RPMI medium supple-
mented with 10% fetal calf serum (BioWhittaker, Walkersville, MD),
10 mM HEPES, 1 mM sodium pyruvate, 2 mM glutamine, 50 M Immunoglobulin Studies
-mercaptoethanol, and 100 U penicillin/streptomycin (Sigma- Chimeric animals were assayed for serum immunoglobulin titers
Aldrich Chemical Co., St. Louis, MO) in 96-well U-bottom plates and/or autoantibodies 4–6 weeks after chimerization by standard
precoated with anti-CD3 (145-2C11, Pharmingen) at the concentra- ELISA (Southern Biotechnology Associates, Birmingham, AL) and/
tions indicated at 5	 104 cells/well. Where indicated, 1g/ml soluble or immunofluorescence protocols, as described (Peng et al.,
anti-CD28 (37.51, Pharmingen) and/or 100 U/ml recombinant human 2001, 2002).
IL-2 (PeproTech, Inc, Rocky Hill, NJ) were added. For Th-neutral
primary stimulation, Th cells were incubated in 12-well tissue culture RNA Transcript Analysis
plates at 0.5 	 106 cells/ml with 1 g/ml plate bound anti-CD3 For RNA analyses, RNA was prepared from cells at the times indi-
and 1 g/ml soluble anti-CD28. For Th1 conditions, cultures were cated in the text with the RNeasy Mini Kit (Qiagen, Inc., Valencia,
supplemented with recombinant murine IL-12 10 ng/ml (PeproTech) CA), and first-strand cDNA synthesized using oligo(dT) primers and
and 10 g/ml anti-IL-4 (11B11, Pharmingen); for Th2 conditions, SuperScript II reverse transcriptase (Invitrogen). Samples were then
cultures were supplemented with 10 ng/ml recombinant murine IL-4 subjected to real-time PCR analysis on an ABI PRISM 7000 Se-
(PeproTech), 10 g/ml anti-IFN-
 (XMG1.2), and 10 g/ml anti-IL-12 quence Detection System (Applied Biosystems, Foster City, CA)
(C17.8, Pharmingen). On day 3–4, T cells were expanded in complete under standard conditions with specificity reinforced via the dissoci-
medium containing 100 U/ml IL-2 and restimulated on day 6 with ation protocol. Foxo3a primers included 5-CCTACTTCAAGGA
1 g/ml plate bound anti-CD3. Where indicated, anti-IL-2 (SB46, TAAGGGCGA and 5-GGTTGTGCCGGATGGAGTT. NF-B, IB, and
Pharmingen) was added at 10 g/ml; phosphorothioate decoy or Foxj1 primers have been previously described (Lin et al., 2004).
control decoy annealed NF-B oligonucleotides, which inhibit the Relative mRNA abundance of each transcript was normalized
activity of all NF-B subunits, were added at 10 M (Khaled et al., against tubulin (Gerth et al., 2003), calculated as 2(Ct[tubulin] – Ct[gene]),
1998). Culture supernatants were assayed for IL-2, IL-4, IL-5, IL-6, where Ct represents the threshold cycle for each transcript.
IL-10, and/or IFN-
 by ELISA (Pharmingen) after 72 hr for primary
stimulations, or 24 hr for secondary stimulations. Apoptosis Studies
Activation-induced cell death was assessed by propidium iodide
T Cell Proliferation Assays staining of purified T cell populations restimulated with IL-2/ anti-
Proliferation was assessed by 5-bromo-2-deoxy-uridine incorpora- CD3 or anti-CD95, after 2 days of primary stimulation with plate
tion (BrdU Labeling and Detection Kit III, Roche Molecular Biochemi- bound anti-CD3 and anti-CD28, as described (Refaeli et al., 2002).
cals, Mannheim, Germany) on day 3 of T cell stimulation after 3–4 For IL-2-withdrawal-induced apoptosis, T cells were activated with
hr of cell labeling. For autologous mixed lymphocyte reactions, CD4 plate bound anti-CD3, anti-CD28, and IL-2 for 3 days, washed exten-
cells were stimulated under Th-neutral conditions, followed by sively, and then resuspended in culture medium in the presence or
expansion in IL-2, as above. Antigen-presenting cells were prepared absence of 100 U/ml IL-2. After 24 hr, apoptotic cells were identified
from syngeneic splenocytes, irradiated by 30 Gy, and combined by propidium iodide staining. For apoptosis in response to anti-CD3
with day 6 primarily stimulated T cells at a 1:1 ratio in complete in vivo, animals were injected intraperitoneally with 20g of a control
medium, 5 	 104 cells per well in a 96-well flat-bottom plate. Where (hamster IgG, Pierce) or anti-CD3 (145-2C11) antibody, as described
indicated, concanavalin A (Calbiochem) was supplemented at 5 (Bouillet et al., 2002). After 48 hr, thymi were harvested and analyzed
g/ml. Proliferation was assessed by BrdU incorporation as above by flow cytometry for the percentages of CD4CD8 thymocytes.
on day 3. For CD95-mediated apoptosis in vivo, female animals were injected
intraperitoneally with 50 g of a control hamster IgG or anti-CD95
(Jo2, Pharmingen) antibody, as described (Ogasawara et al., 1993).Immunohistochemistry
To determine NF-B localization, 293T cells were plated at 0.1 	 Survival was observed at 15–20 min intervals. For apoptosis effects
in vitro, CD4T cells were incubated in culture medium with 20 ng/ml106 cells per well of a 6-well tissue culture plate, each well containing
a cover slip. After growth for 16–20 hr, the cells were infected with anti-CD95 (Jo2), 2 ng/ml phorbol 12-myristate 13-acetate, or 1g/ml
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ionomycin, as described (Bouillet et al., 1999). Viable cell count was a critical effector of cell death induced by cytokine withdrawal:
protein kinase B-enhanced cell survival through maintenance ofdetermined daily thereafter.
mitochondrial integrity. J. Cell Biol. 156, 531–542.
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